GovChime
Notice ID: aa6db2acf9f942c3853a5c9206302a84Special Notice

Oglionucleotide Cards

Responses closed . Full description on SAM.gov.

Overview

Response deadline
7:00 AM PDT
Posted
June 22, 2026
Notice type
Special Notice
Set-aside
No Set aside used
NAICS
325413: In-Vitro Diagnostic Substance Manufacturing
Agency
Department of WarDepartment of the Navy

Notice details

Office
ONR.ONR NRL.NAVAL RESEARCH LABORATORY
Place of performance
Washington, District of Columbia, 20375
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
N0017326Q5252
Notice ID
aa6db2acf9f942c3853a5c9206302a84

Description

NOTICE OF INTENT TO AWARD A SOLE SOURCE

This Notice of Intent is not a request for competitive proposals.  This is not a solicitation or request for offers.  Only one responsible source and no other supplies or services will satisfy agency requirements. 

The Naval Research Laboratory (NRL) intends to award a sole source purchase order to INTEGRATED DNA TECHNOLOGIES to furnish:

OGLIONUCLEOTIDE CARDS

The North American Industry Classification System Code (NAICS) for this requirement is 325413       with the size standard of  1250  .   The Federal Supply Code (FSC) / Product Service Code (PSC) procurement is 6550   .

This purchase will be made utilizing Simplified Acquisition Procedures in accordance with:

Federal Acquisition Regulation (FAR) 12.201-1 for purchases not exceeding the simplified acquisition threshold of $350,000. 

Interested parties may identify their interests and capability to respond to this requirement within fifteen (15) calendar days of the publication of this notice.  Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government.   Information received will be considered solely for the purpose of determining whether or not to conduct a competitive procurement.  A determination by the Government not to compete this proposed purchase order based upon response to this notice is solely within the discretion of the Government.  No reimbursement for any cost connected with providing capability information will be provided.

The point of contact is: Richard Key , email:   richard.a.key2.civ@us.navy.mil.  

Please reference this Notice of Intent number on your correspondence and in the “Subject” line of your email.   

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Documents

No documents available.

Lifecycle

  1. 1
    Version 1Special NoticeCurrent

    Oglionucleotide Cards

    Notice aa6db2acf9f942c3853a5c9206302a84 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Requesting procurement of a high-throughput FDA approved molecular diagnostic testing system and reagents through a rental purchase agreement. Purchase order is requested to order additional specific products throughout the year necessary to perform rapid syndromic infectious disease diagnostic panels.
-Market Research11/27/2026
BD Micro Reagents and Service
-AwardedOpen
CTX BD Micro Reagents and Service Contract
-AwardedOpen
NTX blood bank cost per test
-AwardedOpen
DLA – TS E&A, in conjunction with the United States Army Medical Materiel Center-Europe (USAMMCE), is conducting market research to support the recompete of its commercial laboratory supplies contract. The resulting contract will provide clinical laboratory reagents, test cartridges, calibrators, controls, and associated consumables that operate in conjunction with specific Government-owned laboratory analyzers and capital equipment (e.g., Abbott i-STAT, Siemens DCA 2000, and other point-of-care or automated platforms). The primary ordering activity and logistics hub is USAMMCE, servicing Department of Defense (DoD) medical treatment facilities and operational forces across the European Command (EUCOM) and possibly Central Command (CENTCOM) theaters. The follow-on ordering period is projected to commence on 15 January 2028.
-Market Research10/30/2026

Additional Details

Solicitation Number

N0017326Q5252

Archive Date

Jun 25, 6026

Office Address

WASHINGTON, DC, 20375-5328